Related Experiment Video
Updated: Jun 15, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
IL-4 enhances IFN-lambda1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra
Nicholas J Megjugorac1, Grant E Gallagher, Grant Gallagher
1Humigen LLC, The Institute for Genetic Immunology, Hamilton, NJ 08690, USA.
Abstract:
The type-III interferon (IFN) family is composed of 3 molecules in humans: IFN-lambda1 (interleukin-29 [IL-29]), IFN-lambda2 (IL-28A), and IFN-lambda3 (IL-28B), each of which signals through the same receptor complex. Plasmacytoid dendritic cells (pDCs) are major IFN-lambda producers among peripheral lymphocytes. Recently, it has been shown that IFN-lambda1 exerts a powerful inhibitory effect over the T-helper 2 (Th2) response by antagonizing the effect of IL-4 on CD4(+) T cells and inhibiting the production of Th2-associated cytokines. Here, we asked whether Th2 cytokines exert reciprocal control over IFN-lambda production. IL-4 treatment during stimulation of human peripheral lymphocytes significantly elevated IFN-lambda1 transcription and secretion. However, pDCs were not directly responsive to IL-4. Using depletion and reconstitution experiments, we showed that IL-4-responsive monocytes are an intermediary cell, responding to IL-4 by elevating their secretion of IL-1 receptor antagonist (IL-Ra); this IL-1Ra acts on pDCs to elevate their IFN-lambda1 output. Thus, our experiments revealed a novel mechanism for regulation of both IFN-lambda1 production and pDC function, and suggests an expanded immunomodulatory role for Th2-associated cytokines.
Insights
Interleukin-4 (IL-4) enhances type-III interferon (IFN-lambda1) production by plasmacytoid dendritic cells (pDCs). Monocytes act as intermediaries, mediating this IL-4 effect on pDCs to regulate immune responses.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Type-III interferons (IFN-lambda1, IFN-lambda2, IFN-lambda3) are crucial immune modulators.
- Plasmacytoid dendritic cells (pDCs) are key producers of IFN-lambda.
- IFN-lambda1 inhibits T-helper 2 (Th2) responses by counteracting IL-4 effects.
Purpose of the Study:
- To investigate whether Th2 cytokines reciprocally regulate IFN-lambda production.
- To elucidate the cellular mechanisms underlying IL-4-mediated regulation of IFN-lambda1.
Main Methods:
- Human peripheral lymphocytes were stimulated with IL-4.
- IFN-lambda1 transcription and secretion were measured.
- Depletion and reconstitution experiments identified intermediary cells.
Main Results:
- IL-4 treatment significantly increased IFN-lambda1 transcription and secretion.
- pDCs were not directly responsive to IL-4.
- Monocytes, upon IL-4 stimulation, secreted IL-1 receptor antagonist (IL-Ra), which then induced IFN-lambda1 production in pDCs.
Conclusions:
- A novel regulatory pathway for IFN-lambda1 production and pDC function was discovered.
- Monocytes act as essential intermediaries in IL-4-driven IFN-lambda1 induction.
- Th2 cytokines play an expanded role in immunomodulation through this pathway.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Differentiation of Common Myeloid Progenitor Cells
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

